Click for best price
Cancer Tissue Diagnostics Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Cancer Tissue Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Tissue Diagnostics. This report contains market size and forecasts of Cancer Tissue Diagnostics in global, including the following market information:
Global Cancer Tissue Diagnostics Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Tissue Diagnostics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Immunohistochemistry (IHC) Test Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Tissue Diagnostics include F. Hoffmann-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific Inc., Bio Rad Laboratories Inc., Abbott, Enzo Life Sciences, Inc., Agilent Technologies, Inc., Cancer Genetics Inc. and Merck KGaA (Sigma-Aldrich Co. LLC), etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Tissue Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Tissue Diagnostics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Cancer Tissue Diagnostics Market Segment Percentages, by Type, 2022 (%)
Immunohistochemistry (IHC) Test
In Situ Hybridisation Test
Global Cancer Tissue Diagnostics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Cancer Tissue Diagnostics Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Cancer Tissue Diagnostics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Cancer Tissue Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Tissue Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Tissue Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Thermo Fisher Scientific Inc.
Bio Rad Laboratories Inc.
Abbott
Enzo Life Sciences, Inc.
Agilent Technologies, Inc.
Cancer Genetics Inc.
Merck KGaA (Sigma-Aldrich Co. LLC)
Abcam plc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Tissue Diagnostics, market overview.
Chapter 2: Global Cancer Tissue Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Cancer Tissue Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Tissue Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Cancer Tissue Diagnostics Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
66 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Tissue Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Tissue Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Tissue Diagnostics Overall Market Size
2.1 Global Cancer Tissue Diagnostics Market Size: 2022 VS 2030
2.2 Global Cancer Tissue Diagnostics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Tissue Diagnostics Players in Global Market
3.2 Top Global Cancer Tissue Diagnostics Companies Ranked by Revenue
3.3 Global Cancer Tissue Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Cancer Tissue Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Tissue Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Tissue Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Cancer Tissue Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Tissue Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Tissue Diagnostics Market Size Markets, 2022 & 2030
4.1.2 Immunohistochemistry (IHC) Test
4.1.3 In Situ Hybridisation Test
4.2 By Type - Global Cancer Tissue Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Cancer Tissue Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Cancer Tissue Diagnostics Revenue, 2024-2030
4.2.3 By Type - Global Cancer Tissue Diagnostics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Tissue Diagnostics Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Cancer Tissue Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Cancer Tissue Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Cancer Tissue Diagnostics Revenue, 2024-2030
5.2.3 By Application - Global Cancer Tissue Diagnostics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Cancer Tissue Diagnostics Market Size, 2022 & 2030
6.2 By Region - Global Cancer Tissue Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Cancer Tissue Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Cancer Tissue Diagnostics Revenue, 2024-2030
6.2.3 By Region - Global Cancer Tissue Diagnostics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Cancer Tissue Diagnostics Revenue, 2018-2030
6.3.2 US Cancer Tissue Diagnostics Market Size, 2018-2030
6.3.3 Canada Cancer Tissue Diagnostics Market Size, 2018-2030
6.3.4 Mexico Cancer Tissue Diagnostics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Cancer Tissue Diagnostics Revenue, 2018-2030
6.4.2 Germany Cancer Tissue Diagnostics Market Size, 2018-2030
6.4.3 France Cancer Tissue Diagnostics Market Size, 2018-2030
6.4.4 U.K. Cancer Tissue Diagnostics Market Size, 2018-2030
6.4.5 Italy Cancer Tissue Diagnostics Market Size, 2018-2030
6.4.6 Russia Cancer Tissue Diagnostics Market Size, 2018-2030
6.4.7 Nordic Countries Cancer Tissue Diagnostics Market Size, 2018-2030
6.4.8 Benelux Cancer Tissue Diagnostics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Cancer Tissue Diagnostics Revenue, 2018-2030
6.5.2 China Cancer Tissue Diagnostics Market Size, 2018-2030
6.5.3 Japan Cancer Tissue Diagnostics Market Size, 2018-2030
6.5.4 South Korea Cancer Tissue Diagnostics Market Size, 2018-2030
6.5.5 Southeast Asia Cancer Tissue Diagnostics Market Size, 2018-2030
6.5.6 India Cancer Tissue Diagnostics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Cancer Tissue Diagnostics Revenue, 2018-2030
6.6.2 Brazil Cancer Tissue Diagnostics Market Size, 2018-2030
6.6.3 Argentina Cancer Tissue Diagnostics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Tissue Diagnostics Revenue, 2018-2030
6.7.2 Turkey Cancer Tissue Diagnostics Market Size, 2018-2030
6.7.3 Israel Cancer Tissue Diagnostics Market Size, 2018-2030
6.7.4 Saudi Arabia Cancer Tissue Diagnostics Market Size, 2018-2030
6.7.5 UAE Cancer Tissue Diagnostics Market Size, 2018-2030
7 Cancer Tissue Diagnostics Companies Profiles
7.1 F. Hoffmann-La Roche Ltd.
7.1.1 F. Hoffmann-La Roche Ltd. Company Summary
7.1.2 F. Hoffmann-La Roche Ltd. Business Overview
7.1.3 F. Hoffmann-La Roche Ltd. Cancer Tissue Diagnostics Major Product Offerings
7.1.4 F. Hoffmann-La Roche Ltd. Cancer Tissue Diagnostics Revenue in Global Market (2018-2023)
7.1.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.2 Danaher Corporation
7.2.1 Danaher Corporation Company Summary
7.2.2 Danaher Corporation Business Overview
7.2.3 Danaher Corporation Cancer Tissue Diagnostics Major Product Offerings
7.2.4 Danaher Corporation Cancer Tissue Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Danaher Corporation Key News & Latest Developments
7.3 Thermo Fisher Scientific Inc.
7.3.1 Thermo Fisher Scientific Inc. Company Summary
7.3.2 Thermo Fisher Scientific Inc. Business Overview
7.3.3 Thermo Fisher Scientific Inc. Cancer Tissue Diagnostics Major Product Offerings
7.3.4 Thermo Fisher Scientific Inc. Cancer Tissue Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Thermo Fisher Scientific Inc. Key News & Latest Developments
7.4 Bio Rad Laboratories Inc.
7.4.1 Bio Rad Laboratories Inc. Company Summary
7.4.2 Bio Rad Laboratories Inc. Business Overview
7.4.3 Bio Rad Laboratories Inc. Cancer Tissue Diagnostics Major Product Offerings
7.4.4 Bio Rad Laboratories Inc. Cancer Tissue Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Bio Rad Laboratories Inc. Key News & Latest Developments
7.5 Abbott
7.5.1 Abbott Company Summary
7.5.2 Abbott Business Overview
7.5.3 Abbott Cancer Tissue Diagnostics Major Product Offerings
7.5.4 Abbott Cancer Tissue Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Abbott Key News & Latest Developments
7.6 Enzo Life Sciences, Inc.
7.6.1 Enzo Life Sciences, Inc. Company Summary
7.6.2 Enzo Life Sciences, Inc. Business Overview
7.6.3 Enzo Life Sciences, Inc. Cancer Tissue Diagnostics Major Product Offerings
7.6.4 Enzo Life Sciences, Inc. Cancer Tissue Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Enzo Life Sciences, Inc. Key News & Latest Developments
7.7 Agilent Technologies, Inc.
7.7.1 Agilent Technologies, Inc. Company Summary
7.7.2 Agilent Technologies, Inc. Business Overview
7.7.3 Agilent Technologies, Inc. Cancer Tissue Diagnostics Major Product Offerings
7.7.4 Agilent Technologies, Inc. Cancer Tissue Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Agilent Technologies, Inc. Key News & Latest Developments
7.8 Cancer Genetics Inc.
7.8.1 Cancer Genetics Inc. Company Summary
7.8.2 Cancer Genetics Inc. Business Overview
7.8.3 Cancer Genetics Inc. Cancer Tissue Diagnostics Major Product Offerings
7.8.4 Cancer Genetics Inc. Cancer Tissue Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Cancer Genetics Inc. Key News & Latest Developments
7.9 Merck KGaA (Sigma-Aldrich Co. LLC)
7.9.1 Merck KGaA (Sigma-Aldrich Co. LLC) Company Summary
7.9.2 Merck KGaA (Sigma-Aldrich Co. LLC) Business Overview
7.9.3 Merck KGaA (Sigma-Aldrich Co. LLC) Cancer Tissue Diagnostics Major Product Offerings
7.9.4 Merck KGaA (Sigma-Aldrich Co. LLC) Cancer Tissue Diagnostics Revenue in Global Market (2018-2023)
7.9.5 Merck KGaA (Sigma-Aldrich Co. LLC) Key News & Latest Developments
7.10 Abcam plc.
7.10.1 Abcam plc. Company Summary
7.10.2 Abcam plc. Business Overview
7.10.3 Abcam plc. Cancer Tissue Diagnostics Major Product Offerings
7.10.4 Abcam plc. Cancer Tissue Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Abcam plc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Tissue Diagnostics Market Opportunities & Trends in Global Market
Table 2. Cancer Tissue Diagnostics Market Drivers in Global Market
Table 3. Cancer Tissue Diagnostics Market Restraints in Global Market
Table 4. Key Players of Cancer Tissue Diagnostics in Global Market
Table 5. Top Cancer Tissue Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cancer Tissue Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cancer Tissue Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cancer Tissue Diagnostics Product Type
Table 9. List of Global Tier 1 Cancer Tissue Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Tissue Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cancer Tissue Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Cancer Tissue Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cancer Tissue Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Cancer Tissue Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Cancer Tissue Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cancer Tissue Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Cancer Tissue Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Cancer Tissue Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cancer Tissue Diagnostics Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Cancer Tissue Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cancer Tissue Diagnostics Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Cancer Tissue Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cancer Tissue Diagnostics Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Cancer Tissue Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cancer Tissue Diagnostics Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Cancer Tissue Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cancer Tissue Diagnostics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Cancer Tissue Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cancer Tissue Diagnostics Revenue, (US$, Mn), 2024-2030
Table 30. F. Hoffmann-La Roche Ltd. Company Summary
Table 31. F. Hoffmann-La Roche Ltd. Cancer Tissue Diagnostics Product Offerings
Table 32. F. Hoffmann-La Roche Ltd. Cancer Tissue Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. F. Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 34. Danaher Corporation Company Summary
Table 35. Danaher Corporation Cancer Tissue Diagnostics Product Offerings
Table 36. Danaher Corporation Cancer Tissue Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. Danaher Corporation Key News & Latest Developments
Table 38. Thermo Fisher Scientific Inc. Company Summary
Table 39. Thermo Fisher Scientific Inc. Cancer Tissue Diagnostics Product Offerings
Table 40. Thermo Fisher Scientific Inc. Cancer Tissue Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. Thermo Fisher Scientific Inc. Key News & Latest Developments
Table 42. Bio Rad Laboratories Inc. Company Summary
Table 43. Bio Rad Laboratories Inc. Cancer Tissue Diagnostics Product Offerings
Table 44. Bio Rad Laboratories Inc. Cancer Tissue Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 45. Bio Rad Laboratories Inc. Key News & Latest Developments
Table 46. Abbott Company Summary
Table 47. Abbott Cancer Tissue Diagnostics Product Offerings
Table 48. Abbott Cancer Tissue Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 49. Abbott Key News & Latest Developments
Table 50. Enzo Life Sciences, Inc. Company Summary
Table 51. Enzo Life Sciences, Inc. Cancer Tissue Diagnostics Product Offerings
Table 52. Enzo Life Sciences, Inc. Cancer Tissue Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 53. Enzo Life Sciences, Inc. Key News & Latest Developments
Table 54. Agilent Technologies, Inc. Company Summary
Table 55. Agilent Technologies, Inc. Cancer Tissue Diagnostics Product Offerings
Table 56. Agilent Technologies, Inc. Cancer Tissue Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 57. Agilent Technologies, Inc. Key News & Latest Developments
Table 58. Cancer Genetics Inc. Company Summary
Table 59. Cancer Genetics Inc. Cancer Tissue Diagnostics Product Offerings
Table 60. Cancer Genetics Inc. Cancer Tissue Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 61. Cancer Genetics Inc. Key News & Latest Developments
Table 62. Merck KGaA (Sigma-Aldrich Co. LLC) Company Summary
Table 63. Merck KGaA (Sigma-Aldrich Co. LLC) Cancer Tissue Diagnostics Product Offerings
Table 64. Merck KGaA (Sigma-Aldrich Co. LLC) Cancer Tissue Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 65. Merck KGaA (Sigma-Aldrich Co. LLC) Key News & Latest Developments
Table 66. Abcam plc. Company Summary
Table 67. Abcam plc. Cancer Tissue Diagnostics Product Offerings
Table 68. Abcam plc. Cancer Tissue Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 69. Abcam plc. Key News & Latest Developments
List of Figures
Figure 1. Cancer Tissue Diagnostics Segment by Type in 2022
Figure 2. Cancer Tissue Diagnostics Segment by Application in 2022
Figure 3. Global Cancer Tissue Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Tissue Diagnostics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Cancer Tissue Diagnostics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Tissue Diagnostics Revenue in 2022
Figure 8. By Type - Global Cancer Tissue Diagnostics Revenue Market Share, 2018-2030
Figure 9. By Application - Global Cancer Tissue Diagnostics Revenue Market Share, 2018-2030
Figure 10. By Type - Global Cancer Tissue Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Cancer Tissue Diagnostics Revenue Market Share, 2018-2030
Figure 12. By Application - Global Cancer Tissue Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Cancer Tissue Diagnostics Revenue Market Share, 2018-2030
Figure 14. By Region - Global Cancer Tissue Diagnostics Revenue Market Share, 2018-2030
Figure 15. By Country - North America Cancer Tissue Diagnostics Revenue Market Share, 2018-2030
Figure 16. US Cancer Tissue Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Cancer Tissue Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Cancer Tissue Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Cancer Tissue Diagnostics Revenue Market Share, 2018-2030
Figure 20. Germany Cancer Tissue Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 21. France Cancer Tissue Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Cancer Tissue Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Cancer Tissue Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Cancer Tissue Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Cancer Tissue Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Cancer Tissue Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Cancer Tissue Diagnostics Revenue Market Share, 2018-2030
Figure 28. China Cancer Tissue Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Cancer Tissue Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Cancer Tissue Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Cancer Tissue Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 32. India Cancer Tissue Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Cancer Tissue Diagnostics Revenue Market Share, 2018-2030
Figure 34. Brazil Cancer Tissue Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Cancer Tissue Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Cancer Tissue Diagnostics Revenue Market Share, 2018-2030
Figure 37. Turkey Cancer Tissue Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Cancer Tissue Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Cancer Tissue Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Cancer Tissue Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 41. F. Hoffmann-La Roche Ltd. Cancer Tissue Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Danaher Corporation Cancer Tissue Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Thermo Fisher Scientific Inc. Cancer Tissue Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bio Rad Laboratories Inc. Cancer Tissue Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Abbott Cancer Tissue Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Enzo Life Sciences, Inc. Cancer Tissue Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Agilent Technologies, Inc. Cancer Tissue Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Cancer Genetics Inc. Cancer Tissue Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Merck KGaA (Sigma-Aldrich Co. LLC) Cancer Tissue Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Abcam plc. Cancer Tissue Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
